NDC product
caffeine citrate
NDC 51754-0500 · Exela Pharma Sciences, LLC
Key facts
| Product NDC | 51754-0500 |
|---|---|
| Proprietary name | caffeine citrate |
| Nonproprietary name | caffeine citrate |
| Substances | CAFFEINE CITRATE |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | Exela Pharma Sciences, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA077233 |
| Pharmacologic classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS] |
| Marketing start | Mar 30, 2015 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: